China shares biobank with researchers worldwide

english.shanghai.gov.cn| November 17, 2026
6afab66ee4b03ebf7463ac87.jpeg
​Shanghai Ruijin Hospital announces the latest achievements of the China Metabolic Analytics Project on Nov 14. [Photo provided to International Services Shanghai]

Shanghai Ruijin Hospital announced the latest achievements of the China Metabolic Analytics Project (ChinaMAP), the most comprehensive genomics database in China to date, on Nov 14, this year's World Diabetes Day, and declared it open to the global community.

The database is expected to facilitate international cooperation in research into global health challenges associated with metabolic diseases and tumors.

Metabolic diseases include not only diabetes, obesity, and cardiovascular diseases, but are also closely linked to tumors and represent a major risk factor accelerating aging, according to medical experts.

Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, said that large-scale, evidence-based medical data from the Chinese population are important for understanding the global evolution of metabolic diseases.

Jointly spearheaded by the National Clinical Research Center for Metabolic Diseases at Ruijin and a number of research institutions and hospitals nationwide, the database is a comprehensive biobank integrating nationwide cohort studies.

Wang Weiqing, director of the national center at Ruijin, said the database aggregates research resources from 5 million people and tens of millions of biological samples. This creates an original data foundation tailored to the Chinese population, overcoming the past reliance on data from European and American populations in related genetic research.

She noted that previously, international basic research, including genetic studies of metabolic diseases and genetic mapping of certain endocrine and classic tumor diseases, predominantly relied on data from Caucasian populations.

"With ChinaMAP, we can provide local evidence for the precise prediction and intervention of metabolic diseases and offer important references for related research in East Asian and surrounding populations," said Wang.

 

Source: China Daily